Latest Headlines

  1. MilliporeSigma Introduces Comprehensive AAV Express Platform For Streamlined Gene Therapy Production 10/17/2025
  2. Ensera Launches As New Brand Identity For SteriPack 10/14/2025

    New trading name reflects expanded expertise across design, manufacturing, assembly and packing for global pharma and medical device companies.

  3. TORL Biotherapeutics Secures $96M For ADC Drug Development From UCLA Lab 10/7/2025

    TORL BioTherapeutics LLC (TORL), a clinical stage biotechnology company discovering and developing new antibody-based immunotherapies to improve and extend the lives of patients with cancer worldwide, today announced closing of a $96 million Series C financing. Additionally, updated results from the ongoing Phase 1 study of the Company's Claudin 6 (CLDN6) targeted antibody-drug conjugate (ADC) TORL-1-23 in patients with advanced cancer will be presented in poster sessions at the 2025 European Society of Medical Oncology Congress (ESMO 2025) in Berlin, Germany.

  4. RoosterBio And Secretome Therapeutics Announce Successful Completion Of Large Scale Bioreactor Production For Clinical Stage Cell Therapy Candidate STM-01 10/6/2025

    RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and Secretome Therapeutics, a clinic-stage company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC) today announced completion of commercial scale production of Secretome’s lead nCPC, STM-01.

  5. AAV Producer Cell Lines, A New Standard For Viral Vector Manufacturing 10/6/2025

    Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the launch of its AAV Edge Stable Producer System. With this launch, Asimov aims to address the shortcomings of traditional transient transfection-based production and bring AAV manufacturing standards closer to those established for antibody-based biologics.

  6. CDMO AbbVie Begins Construction On Biologics Manufacturing Facility Expansion In Massachusetts 10/2/2025

    AbbVie today announced the start of construction of a $70 million expansion at its AbbVie Bioresearch Center (ABC) in Worcester, Mass., which serves as a center of excellence for biologics research and development and manufacturing. This expansion is part of the company's previously announced commitment to invest more than $10 billion of capital in the U.S. to broadly support innovation and expand critical biologics manufacturing capabilities and capacity.

  7. Federal Equipment Company Announces Exclusive Sale Of Brand-New Aseptic Processing & Sterilization Equipment 10/2/2025

    Federal Equipment Company is pleased to announce the exclusive consignment of a suite of brand-new, never-used equipment designed for pharmaceutical and biotech aseptic processing. These state-of-the-art systems from leading manufacturers are now available for immediate purchase, offering buyers a unique opportunity to acquire high-performance technologies without the typical lead times of new builds.

  8. Bora Pharmaceuticals Wins Canada's Safest New Employer Award 10/1/2025

    Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), a global leader in pharmaceutical manufacturing, was named this year’s winner of The Bruce Power Award for Canada’s Safest New Employer. The award, announced during the 2025 Canada’s Safest Employers ceremony in October, recognizes an exemplary safety record in less than 10 years of operation.

  9. Bora Pharmaceuticals Introduces High-Potency Liquid Capsule Technology In Taiwan 9/30/2025

    Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, has announced the addition of liquid-filled hard capsule (LFC) production capabilities at its Zhunan, Taiwan facility.

  10. Launch Of The Next Syringe Production Line 9/23/2025